Li W, Du C, Wang H, Zhang C
Department of Nuclear Medicine, Qianfoshan Hospital Affiliated to Shandong University, Jinan, China.
Department of Nuclear Medicine, Qianfoshan Hospital Affiliated to Shandong University, Jinan, China
Genet Mol Res. 2014 Nov 14;13(4):9642-9. doi: 10.4238/2014.November.14.9.
We compared serum levels of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-4, ADAMTS-5, matrix metalloproteinase (MMP)-1, and MMP-3 in patients with different stages of knee osteoarthritis (OA), and investigated the clinical significance of diagnosing OA in early stages. OA patients were divided into 2 groups: early OA group (44 cases), intermediate and advanced OA group (26 cases). The healthy control group included 30 samples. ADAMTS-4, ADAMTS-5, MMP-1, and MMP-3 levels in the serum were tested using an enzyme-linked immunosorbent assay. A protein-protein interaction network was constructed by seeding the significantly expressed marker, followed by Gene Ontology enrichment analyses using Database for Annotation, Visualization and Integrated Discovery. ADAMTS-4 levels were significantly higher in patients at early stages of OA compared to intermediate or advanced OA and healthy controls. ADAMTS-5, MMP-1, and MMP-3 levels in intermediate and advanced-stage OA patients were significantly higher than those in early-stage OA patients and healthy controls. The protein-protein interaction network showed that ADAMTS-4 participates in 67 interactions. Gene Ontology enrichment analysis validated that genes associated with ADAMTS-4 participate in collagen metabolism and OA. ADAMTS-4 is a potential biomarker as an early diagnostic indicator of OA.
我们比较了不同阶段膝关节骨关节炎(OA)患者血清中含血小板反应蛋白基序的解聚素和金属蛋白酶(ADAMTS)-4、ADAMTS-5、基质金属蛋白酶(MMP)-1和MMP-3的水平,并探讨了早期诊断OA的临床意义。OA患者分为2组:早期OA组(44例),中晚期OA组(26例)。健康对照组包括30个样本。采用酶联免疫吸附测定法检测血清中ADAMTS-4、ADAMTS-5、MMP-1和MMP-3的水平。通过植入显著表达的标志物构建蛋白质-蛋白质相互作用网络,随后使用注释、可视化和综合发现数据库进行基因本体富集分析。与中晚期OA患者和健康对照组相比,OA早期患者的ADAMTS-4水平显著更高。中晚期OA患者的ADAMTS-5、MMP-1和MMP-3水平显著高于早期OA患者和健康对照组。蛋白质-蛋白质相互作用网络显示ADAMTS-4参与67种相互作用。基因本体富集分析证实,与ADAMTS-4相关的基因参与胶原蛋白代谢和OA。ADAMTS-4作为OA的早期诊断指标是一种潜在的生物标志物。